Wintest
6721
Ridge-i
5572
D. Western Therapeutics Institute
4576
Forside
2330
Fit Easy
212A
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | 25.20%77.9B | -0.03%67.86B | 23.09%7.36B | 33.40%223.73B | 43.00%87.65B | 14.22%62.22B | 58.56%67.88B | -34.58%5.98B | -23.78%167.72B | 5.59%61.3B |
Net profit before non-cash adjustment | 52.67%39.61B | 96.26%39.64B | 193.45%24.76B | -44.89%63.84B | -69.89%9.26B | 5.36%25.94B | -41.98%20.2B | -67.10%8.44B | -22.77%115.85B | -15.73%30.75B |
Total adjustment of non-cash items | -33.02%31.98B | -46.61%20.7B | 9.10%-4.62B | 59.49%116.47B | 89.61%35.02B | 42.56%47.75B | 80.37%38.78B | -1,062.24%-5.08B | -33.06%73.03B | -65.67%18.47B |
-Depreciation and amortization | -1.62%22.07B | -0.78%22.29B | -0.19%22.07B | -0.16%89.6B | -1.22%22.59B | -1.82%22.43B | 0.21%22.47B | 2.35%22.11B | 2.74%89.74B | 5.50%22.87B |
-Reversal of impairment losses recognized in profit and loss | -98.02%207M | ---- | ---- | 63,732.35%21.7B | 9,641.18%3.31B | --10.46B | ---- | ---- | --34M | --34M |
-Share of associates | -31.94%-1.14B | -35.05%-497M | -42.46%-1.12B | 6.21%-2.39B | 64.31%-369M | -1,003.85%-861M | 36.22%-368M | 7.83%-789M | 2.86%-2.55B | -59.57%-1.03B |
-Disposal profit | -783.72%-9.74B | -28.05%726M | -62.31%326M | 35.75%4.78B | 5.02%1.49B | 58.33%1.43B | 57.90%1.01B | 51.49%865M | -20.95%3.52B | -19.43%1.41B |
-Other non-cash items | 43.97%20.59B | -130.71%-2.38B | 5.06%-25.88B | 115.67%2.78B | 266.49%8.01B | 45.55%14.3B | 884.28%7.73B | -25.33%-27.26B | -188.97%-17.72B | -115.51%-4.81B |
Changes in working capital | 154.99%6.31B | -15.63%7.51B | -588.02%-12.79B | 305.24%43.42B | 259.30%43.37B | -215.16%-11.47B | 165.87%8.9B | 116.30%2.62B | 45.83%-21.15B | 137.43%12.07B |
-Change in receivables | 259.59%14.89B | -168.35%-2.96B | -69.61%7.73B | 503.30%20.48B | 100.30%58M | -209.63%-9.33B | 207.45%4.33B | 39.39%25.42B | 176.44%3.39B | 38.38%-19.32B |
-Change in inventory | -141.53%-2.75B | -54.79%5.55B | 25.44%-5.91B | 179.56%29.38B | 54.91%18.39B | 154.56%6.63B | 184.04%12.28B | 64.07%-7.92B | -80.08%-36.93B | 42.67%11.87B |
-Change in payables | 209.41%8.91B | 120.49%1.32B | 6.74%-12.79B | -452.62%-19.38B | -13.08%8.9B | -1,722.91%-8.15B | -213.47%-6.42B | -25.80%-13.72B | -36.70%5.5B | 32.84%10.24B |
-Provision for loans, leases and other losses | -2,262.18%-14.74B | 377.47%3.6B | -56.24%-1.81B | 87.89%12.94B | 72.66%16.02B | -23.56%-624M | -148.75%-1.3B | 15.01%-1.16B | 130.22%6.89B | 154.84%9.28B |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | -4,508.33%-553M | 223.50%592M | 5.38%2.23B | 5.45%2.65B | 704.44%362M | -116.67%-12M | -48.01%183M | 3.57%2.12B | 13.10%2.51B | -6.25%45M |
Interest paid (cash flow from operating activities) | -21.29%-604M | -4.18%-598M | -8.35%-506M | -36.13%-2.6B | -112.68%-1.06B | -4.18%-498M | -11.89%-574M | -11.46%-467M | 6.47%-1.91B | 5.87%-497M |
Interest received (cash flow from operating activities) | 56.86%1.18B | 40.67%1.09B | 53.06%1.1B | 73.39%3.33B | 56.73%1.08B | 49.90%751M | 109.43%777M | 101.12%718M | 61.21%1.92B | 137.46%691M |
Tax refund paid | -120.39%-10.16B | 66.20%-1.03B | -25.15%-13.95B | 37.38%-24.63B | -53.98%-5.83B | 49.70%-4.61B | 40.89%-3.05B | 47.49%-11.15B | 14.29%-39.34B | -4.27%-3.78B |
Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating cash flow | 17.13%67.76B | 4.14%67.91B | -34.51%-3.77B | 54.68%202.48B | 42.36%82.22B | 27.41%57.86B | 72.26%65.21B | 72.29%-2.8B | -25.42%130.91B | 6.49%57.75B |
Investing cash flow | ||||||||||
Net PPE purchase and sale | -6.23%-15.4B | 22.91%-10.92B | 19.75%-10.4B | 17.33%-54.17B | 8.71%-12.55B | 1.98%-14.49B | 39.46%-14.17B | 4.65%-12.96B | -9.29%-65.52B | -0.27%-13.75B |
Net intangibles purchase and sale | 26.66%-2.12B | 21.89%-2.32B | 21.19%-2.02B | -5.14%-12.28B | 7.29%-3.87B | -2.38%-2.89B | -35.25%-2.97B | -2.53%-2.56B | -0.98%-11.68B | 2.46%-4.17B |
Net business purchase and sale | ---- | ---- | ---- | ---40.83B | ---- | ---- | ---- | ---- | --0 | ---- |
Net investment product transactions | 1,142.19%795M | 107.58%124M | -746.99%-2.26B | -181.79%-2.65B | -175.37%-1.42B | -50.39%64M | -231.75%-1.64B | 1,554.17%349M | 113.89%3.23B | 1,150.33%1.89B |
Net changes in other investments | -2,663.02%-4.92B | 1,182.15%5.6B | 3,192.00%1.65B | 165.25%616M | 59.09%-63M | 115.99%192M | 3,013.33%437M | -88.26%50M | -134.02%-944M | -118.87%-154M |
Investing cash flow | 42.44%-9.86B | 59.02%-7.51B | 13.83%-13.03B | -45.91%-109.3B | -262.86%-58.73B | 8.32%-17.12B | 24.76%-18.33B | 3.61%-15.12B | -11.42%-74.91B | 4.91%-16.19B |
Financing cash flow | ||||||||||
Net issuance payments of debt | -104.93%-148M | -220.55%-11.45B | 163,580.00%8.17B | 3,638.15%9.55B | -180.96%-2.94B | 225.81%3B | 784.72%9.5B | 96.15%-5M | 68.20%-270M | 4,277.01%3.63B |
Net common stock issuance | ---- | ---- | ---- | 99.97%-17M | 0.00%-4M | ---- | ---- | ---- | 3.39%-50.04B | -100.00%-4M |
Increase or decrease of lease financing | -2.97%-5.51B | 0.65%-5.36B | 0.86%-5.28B | 1.25%-21.43B | 0.76%-5.37B | 2.10%-5.35B | 1.48%-5.39B | 0.65%-5.32B | -2.06%-21.7B | -2.35%-5.41B |
Cash dividends paid | -1.88%-34.73B | 8.90%-686M | -1.56%-34.21B | -0.59%-69.34B | -4.49%-815M | -0.26%-34.09B | -7.26%-753M | -0.70%-33.68B | -1.58%-68.93B | -10.33%-780M |
Cash dividends for minorities | -17.95%-46M | -5.76%-973M | 33.33%-2M | -129.59%-962M | --0 | 81.60%-39M | -350.98%-920M | 0.00%-3M | 47.76%-419M | --0 |
Net other fund-raising expenses | -66.67%3M | -1,881.94%-2.76B | -100.44%-9M | 8.11%2.21B | 50.00%-1M | 350.00%9M | -92.46%155M | 25,737.50%2.05B | 105.83%2.05B | -101.00%-2M |
Financing cash flow | -10.83%-40.43B | -921.24%-21.23B | 15.26%-31.32B | 42.59%-79.98B | -256.60%-9.13B | 47.52%-36.48B | 109.14%2.59B | 5.09%-36.96B | 1.60%-139.31B | 56.46%-2.56B |
Net cash flow | ||||||||||
Beginning cash position | 10.27%303.98B | 16.96%253.54B | 8.73%291.66B | -20.18%268.25B | 18.08%283.36B | -1.73%275.66B | -23.11%216.77B | -20.18%268.25B | -4.84%336.07B | -19.73%239.98B |
Current changes in cash | 311.13%17.48B | -20.81%39.17B | 12.32%-48.12B | 115.84%13.2B | -63.19%14.36B | 109.94%4.25B | 434.10%49.46B | 15.23%-54.88B | -150.34%-83.32B | 24.49%39.01B |
Effect of exchange rate changes | -592.44%-16.99B | 19.52%11.27B | 194.31%9.99B | -34.05%10.22B | 43.57%-6.06B | 54.68%3.45B | -29.63%9.43B | -67.98%3.39B | -4.19%15.5B | -286.07%-10.74B |
End cash Position | 7.45%304.46B | 10.27%303.98B | 16.96%253.54B | 8.73%291.66B | 8.73%291.66B | 18.08%283.36B | -1.73%275.66B | -23.11%216.77B | -20.18%268.25B | -20.18%268.25B |
Free cash flow | 23.64%50.2B | 3.52%49.63B | 11.65%-16.18B | 153.30%136.03B | 65.19%65.8B | 46.03%40.6B | 290.96%47.95B | 30.08%-18.32B | -48.36%53.7B | 9.90%39.83B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |